Cleared Traditional

K163673 - Fortilink™-C with TETRAfuse™ 3D Technology (FDA 510(k) Clearance)

May 2017
Decision
147d
Days
Class 2
Risk

K163673 is an FDA 510(k) clearance for the Fortilink™-C with TETRAfuse™ 3D Technology. This device is classified as a Intervertebral Fusion Device With Bone Graft, Cervical (Class II - Special Controls, product code ODP).

Submitted by Rti Surgical, Inc. (Alachua, US). The FDA issued a Cleared decision on May 23, 2017, 147 days after receiving the submission on December 27, 2016.

This device falls under the Orthopedic FDA review panel. Regulated under 21 CFR 888.3080. Intended To Stabilize Cervical Spinal Segment To Promote Fusion In Order To Restrict Motion And Decrease Pain Using Bone Graft..

Submission Details

510(k) Number K163673 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 27, 2016
Decision Date May 23, 2017
Days to Decision 147 days
Submission Type Traditional
Review Panel Orthopedic (OR)
Summary Summary PDF

Device Classification

Product Code ODP - Intervertebral Fusion Device With Bone Graft, Cervical
Device Class Class II - Special Controls
CFR Regulation 21 CFR 888.3080
Definition Intended To Stabilize Cervical Spinal Segment To Promote Fusion In Order To Restrict Motion And Decrease Pain Using Bone Graft.

Similar Devices - ODP Intervertebral Fusion Device With Bone Graft, Cervical

All 32
Flex-Z™ Cervical Cage
K252432 · Spinepoint, LLC · Mar 2026
Hive™ Standalone Cervical System and Hive™ C Interbody System
K254105 · NanoHive Medical, LLC · Feb 2026
Curiteva Porous PEEK Cervical Interbody System
K252205 · Curiteva, Inc. · Jan 2026
Curiteva Porous PEEK Cervical Interbody Fusion System
K254061 · Curiteva, Inc. · Jan 2026
Cervical Interbody and VBR Fusion System
K252219 · Sync Surgical · Jan 2026
Advantage-C™ Ti3D Cervical Interbody Fusion Device
K252711 · Intelivation Technologies · Jan 2026